Long-term efficacy and safety of luspatercept for the treatment of anaemia
Lancet Haematol. 2025 Mar;12(3):e180-e189
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
N Engl J Med. 2020 Mar 26;382(13):1219-1230
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia
N Engl J Med. 2024;390:1663-76
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassemia
Lancet Haematol. 2022 Oct;9(10):e733-e744
Mitapivat in adults with non-transfusion-dependent thalassemia
Lancet. 2025 Jul 5;406(10498):33-42
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent β-thalassemia
Lancet. 2024;404:2175–86
Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia
N Engl J Med. 2022 Feb 3;386(5):415-27
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
N Engl J Med. 2018 Apr 19;378(16):1479